Literature DB >> 22540147

Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Likui Yang1, Qiulan Ding, Xin Huang, Steven T Olson, Alireza R Rezaie.   

Abstract

High-molecular weight heparins promote the protein Z-dependent protease inhibitor (ZPI) inhibition of factors Xa (FXa) and XIa (FXIa) by a template mechanism. To map the heparin-binding site of ZPI, the role of basic residues of the D-helix (residues Lys-113, Lys-116, and Lys-125) in the interaction with heparin was evaluated by either substituting these residues with Ala (ZPI-3A) or replacing the D-helix with the corresponding loop of the non-heparin-binding serpin α(1)-proteinase inhibitor (ZPI-D-helix(α1-PI)). Furthermore, both the C-helix (contains two basic residues, Lys-104 and Arg-105) and the D-helix of ZPI were substituted with the corresponding loops of α(1)-proteinase inhibitor (ZPI-CD-helix(α1-PI)). All mutants exhibited near normal reactivity with FXa and FXIa in the absence of cofactors and in the presence of protein Z and membrane cofactors. By contrast, the mutants interacted with heparin with a lower affinity and the ~48-fold heparin-mediated enhancement in the rate of FXa inhibition by ZPI was reduced to ~30-fold for ZPI-3A, ~15-fold for ZPI-D-helix(α1-PI), and ~8-fold for ZPI-CD-helix(α1-PI). Consistent with a template mechanism for heparin cofactor action, ZPI-CD-helix(α1-PI) inhibition of a FXa mutant containing a mutation in the heparin-binding site (FXa-R240A) was minimally affected by heparin. A significant decrease (~2-5-fold) in the heparin template effect was also observed for the inhibition of FXIa by ZPI mutants. Interestingly, ZPI derivatives exhibited a markedly elevated stoichiometry of inhibition with FXIa in the absence of heparin. These results suggest that basic residues of both helices C and D of ZPI interact with heparin to modulate the inhibitory function of the serpin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540147      PMCID: PMC3352997          DOI: 10.1021/bi300353c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.

Authors:  Srikumar M Raja; Neetu Chhablani; Richard Swanson; Elizabeth Thompson; Mike Laffan; David A Lane; Steven T Olson
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

3.  Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.

Authors:  A R Rezaie
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

4.  Helix D elongation and allosteric activation of antithrombin.

Authors:  Klara J Belzar; Aiwu Zhou; Robin W Carrell; Peter G W Gettins; James A Huntington
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

5.  Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.

Authors:  S T Olson; J D Shore
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

6.  Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.

Authors:  Xin Huang; Alexey Dementiev; Steven T Olson; Peter G W Gettins
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

7.  Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.

Authors:  Xin Huang; Alireza R Rezaie; George J Broze; Steven T Olson
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

8.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

9.  Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.

Authors:  A R Rezaie; S T Olson
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

10.  Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.

Authors:  A Tabatabai; R Fiehler; G J Broze
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

View more
  8 in total

1.  Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Authors:  Xin Huang; Baoxin Liu; Yidong Wei; Ryan Beyea; Han Yan; Steven T Olson
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

2.  Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

3.  Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).

Authors:  David Ulbricht; Kathrin Oertwig; Kristin Arnsburg; Anja Saalbach; Jan Pippel; Norbert Sträter; John T Heiker
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

4.  Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.

Authors:  Shabir H Qureshi; Qiuya Lu; Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochim Biophys Acta       Date:  2014-06-21

5.  Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism.

Authors:  Hudie Wei; Haiyan Cai; Jiawei Wu; Zhenquan Wei; Fei Zhang; Xin Huang; Lina Ma; Lingling Feng; Ruoxi Zhang; Yunjie Wang; Hermann Ragg; Ying Zheng; Aiwu Zhou
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

6.  Characterization of Protein Z-Dependent Protease Inhibitor/Antithrombin Chimeras Provides Insight into the Serpin Specificity of Coagulation Proteases.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  ACS Omega       Date:  2017-07-07

7.  Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.

Authors:  Xin Huang; Richard Swanson; Steven T Olson
Journal:  J Biol Chem       Date:  2022-05-10       Impact factor: 5.486

8.  Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion.

Authors:  Lina Ma; Jiawei Wu; Ying Zheng; Zimei Shu; Zhenquan Wei; Yinbiao Sun; Robin W Carrell; Aiwu Zhou
Journal:  Biomolecules       Date:  2020-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.